Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and targeted anti-inflammatory treatments can improve outcomes in androgenetic alopecia with perifollicular inflammation and fibrosis.

Current treatments for cicatricial alopecia can manage symptoms but don't stop hair loss or the disease.

Patients with systemic lupus erythematosus and hair loss had fewer hair follicles and non-scarring alopecia; direct immunofluorescence was not helpful in diagnosing lupus in these cases.

Combining nonablative fractional laser with minoxidil was effective for alopecia areata with only one patient relapsing after a year.

Using a nonablative fractional laser with topical minoxidil can effectively and safely promote hair regrowth in alopecia areata patients.

Laser hair removal can be an effective last-resort treatment for men with stubborn Alopecia Areata who want to be uniformly bald.

A 12-year-old boy has a rare, harmless hair loss on his chin with no need for treatment.

Intralesional steroids are the most effective treatment for alopecia areata.

The 2003 guidelines suggest that while some treatments can regrow hair in alopecia areata, none alter the disease's progression, and wigs may be the best option for extensive hair loss.

Hair transplantation for Frontal Fibrosing Alopecia may work if the disease is inactive for 2 years and with ongoing treatment to maintain results.

Blocking certain proteins on immune cells may help treat alopecia areata.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

Trichoscopy helps diagnose scarring alopecia early and non-invasively.

Stopping the use of a tight headband and using specific treatments led to partial hair regrowth.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Early diagnosis and strong corticosteroids are crucial for managing lymphocytic cicatricial alopecia.

Alopecia areata treatments should be personalized, using options like steroids, JAK inhibitors, and other therapies based on individual needs.

Proper diagnosis and treatment of childhood hair loss require distinguishing between alopecia and trichotillomania.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Thinner hair follicle structures are linked to non-scar alopecia.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

Early detection and histopathology are crucial to prevent permanent hair loss in cicatricial alopecia.

Alternative treatments with nutrients, minerals, and vitamins are being explored for safer hair loss management.

Cytokeratin-15 loss is not specific to any single type of scarring alopecia.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

Primary idiopathic pseudopelade of Brocq causes gradual, scarring hair loss with no effective treatment.

New treatments for androgenetic alopecia are emerging, improving hair loss management.